Drug resistance among students with pulmonary tuberculosis: a study based on screening in Henan, China
- PMID: 40781271
- PMCID: PMC12333275
- DOI: 10.1186/s12879-025-11408-1
Drug resistance among students with pulmonary tuberculosis: a study based on screening in Henan, China
Abstract
Background: Tuberculosis (TB) can easily spread among students and can lead to an outbreak once there is an infection in a school. Outbreaks of drug-resistant TB (DR-TB) in schools have occasionally been reported, but the profile of DR-TB in students in a province has rarely been described. This study was conducted to determine the prevalence of DR-TB and factors associated with it in students in Henan Province, China.
Methods: We retrospectively reviewed the data of 3527 pulmonary TB patients among students with culture-confirmed Mycobacterium tuberculosis (M.tb) isolates collected from the Tuberculosis Information Management System of the China Disease Prevention and Control Information System from 2015 to 2021. Prevalence of DR-TB was analyzed. Comparisons between categorical variables were analyzed using the chi-square test or Fisher's exact test as appropriate. Logistic regression models were used to identify the factors associated with DR-TB.
Results: Any DR-, RR (rifampin resistance)- and MDR (multi-drug resistance) -TB rates in students were 10.46%, 7.91% and 6.10%, respectively. And they all showed a downward trend from 2015 to 2021 (p < 0.001). Previously treated cases were 7.30 (95% CI: 5.30, 10.05), 8.60 (95% CI: 6.14,12.14) and 9.43 (95% CI: 6.64,13.40) times more likely than the new cases to be diagnosed with Any DR-TB, RR-TB and MDR-TB, respectively. Patients from schools in the western region of Henan had greater odds of having Any DR- (AOR = 2.06, 95% CI: 1.31, 3.24), RR- (AOR = 2.81, 95% CI: 1.66, 4.76) and MDR-TB (AOR = 2.07, 95% CI: 1.13, 3.80) than those from schools in the northern region. Males had a 1.40-fold (95% CI: 1.11, 1.78), 1.34-fold (95% CI: 1.02, 1.75) greater likelihood of being diagnosed with Any DR- and RR-TB, respectively. The risk of being diagnosed with MDR-TB was 1.42 (95% CI: 1.00, 2.02) times greater in students migrant between prefectures of the province than in the locals.
Conclusion: The prevalence of DR-TB among students with PTB in Henan, China, significantly decreased from 2015 to 2021. Previous treated cases and those in west-region schools in Henan were at greater risk of being diagnosed with Any DR-, RR- and MDR-TB. In addition, males were more likely to be diagnosed with Any DR- and RR-TB. It requires further study that whether those who migrated between prefectures of the province were more likely to be diagnosed with MDR-TB.
Keywords: Drug resistance; Student; Tuberculosis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Human Ethics and Consent to Participate: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Drug resistance profile of Mycobacterium tuberculosis complex isolated from pulmonary tuberculosis patients and their household contacts in central Ethiopia.BMC Infect Dis. 2025 Jun 20;25(1):806. doi: 10.1186/s12879-025-11220-x. BMC Infect Dis. 2025. PMID: 40542339 Free PMC article.
-
Treatment outcomes in cavitary multidrug-resistant/rifampicin-resistant tuberculosis and risk factors for cavity closure: a retrospective cohort study in Southwest China.Sci Rep. 2025 Jul 1;15(1):21302. doi: 10.1038/s41598-025-06080-z. Sci Rep. 2025. PMID: 40596245 Free PMC article.
-
Treatment outcomes of multi-drug-resistant and rifampicin-resistant tuberculosis with and without isolation of nontuberculous mycobacteria between 2018-2021: A retrospective cohort study in Ghana.PLoS Negl Trop Dis. 2025 Jul 2;19(7):e0013204. doi: 10.1371/journal.pntd.0013204. eCollection 2025 Jul. PLoS Negl Trop Dis. 2025. PMID: 40601698 Free PMC article.
-
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 Jun 07;6:CD009593. doi: 10.1002/14651858.CD009593.pub4. PMID: 24448973 Free PMC article. Updated.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
References
-
- World Health Organization. Global tuberculosis report 2023. Geneva: 2023.
-
- Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547–67. - PubMed
-
- Wang Shengfen Z, Yang O, Xichao, et al. Drug resistance of tuberculosis in china: analysis of National drug resistance surveillance data of tuberculosis in 2018 [J]. Chin J Antituberc. 2022;44(11):1141–7.
-
- World Health Organization. Anti-tuberculosis drug resistance in the world. Report no.4. WHO/HTM/TB/2008.394. Geneva, Switzerland: World Health Organization; 2008.
-
- World Health Organization. Anti-tuberculosis drug resistance in the world. Report no.3. WHO/HTM/TB/2004.343. Geneva, Switzerland: World Health Organization; 2004.
MeSH terms
Substances
Grants and funding
- 212102310156/Henan Province Scientific Research Project
- 212102310156/Henan Province Scientific Research Project
- 212102310156/Henan Province Scientific Research Project
- LHGJ20230624/Henan Province Medical Science and Technology Project
- LHGJ20230624/Henan Province Medical Science and Technology Project
- LHGJ20230624/Henan Province Medical Science and Technology Project
- LHGJ20230624/Henan Province Medical Science and Technology Project
- LHGJ20230624/Henan Province Medical Science and Technology Project
- LHGJ20230624/Henan Province Medical Science and Technology Project
- LHGJ20230624/Henan Province Medical Science and Technology Project
- 2017ZX10201302-006/Key Project of Chinese National Programs
LinkOut - more resources
Full Text Sources